⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2629415 | 0.71 | — | — | |
| SCHEMBL1741746 | 0.67 | — | — | |
| SCHEMBL1696953 | 0.67 | — | — | |
| SCHEMBL844387 | 0.67 | — | — | |
| SCHEMBL2629414 | 0.67 | — | — | |
| SCHEMBL82304 | 0.64 | — | — | |
| SCHEMBL19673045 | 0.63 | — | — | |
| SCHEMBL18720843 | 0.63 | — | — | |
| SCHEMBL844034 | 0.63 | — | — | |
| SCHEMBL8380266 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11911503-B2 | Manufacturing of semi-plastic pharmaceutical dosage units | INTERVET INC. (US) | 2024-02-27 | — | — | US | disclosed |
| US-11858904-B2 | Process for preparing large size isoxazoline particles | INTERVET INC. (JE) | 2024-01-02 | — | — | US | disclosed |
| US-20230320981-A1 | SOLID ORAL PHARMACEUTICAL COMPOSITIONS FOR ISOXAZOLINE COMPOUNDS | INTERVET INC. (US) | 2023-10-12 | — | — | US | disclosed |
| US-20230310386-A1 | INJECTABLE PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | INTERVET INC. (US) | 2023-10-05 | — | — | US | disclosed |
| US-11712416-B2 | Solid oral pharmaceutical compositions for isoxazoline compounds | INTERVET INC. (US) | 2023-08-01 | — | — | US | disclosed |
| US-20230233530-A1 | IMPLANTABLE ISOXAZOLINE PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | INTERVET INC. (US) | 2023-07-27 | — | — | US | disclosed |
| US-11648238-B2 | Implantable isoxazoline pharmaceutical compositions and uses thereof | INTERVET INC. (US) | 2023-05-16 | — | — | US | disclosed |
| US-11552266-B2 | Electrodes for electronic devices comprising an organic semiconducting layer | FLEXENABLE LIMITED (GB) | 2023-01-10 | — | — | US | disclosed |
| US-20220193040-A1 | Use of Isoxazoline Derivatives for the Treatment or Prevention of Arthropod Infestations in Poultry | INTERVET INC. (US) | 2022-06-23 | — | — | US | disclosed |
| US-11337917-B2 | Soft chewable pharmaceutical products | INTERVET INC. (US) | 2022-05-24 | — | — | US | disclosed |
| US-20170266165-A1 | Soft Chewable Pharmaceutical Products | INTERVET INC. (US) | 2017-09-21 | — | — | US | disclosed |
| US-20170172918-A1 | SOFT CHEWABLE PHARMACEUTICAL PRODUCTS | INTERVET, INC. (US) | 2017-06-22 | — | — | US | disclosed |
| US-20170172986-A1 | SOFT CHEWABLE PHARMACEUTICAL PRODUCTS | INTERVET, INC. (US) | 2017-06-22 | — | — | US | disclosed |
| US-20170157040-A1 | Manufacturing of Semi-Plastic Pharmaceutical Dosage Units | INTERVET INC. (US) | 2017-06-08 | — | — | US | disclosed |
| US-9655884-B2 | Antiparasitic use of isoxazoline compounds | INTERVET INC. (US) | 2017-05-23 | — | — | US | disclosed |
| US-20170105972-A1 | SOFT CHEWABLE PHARMACEUTICAL PRODUCTS | INTERVET, INC. (US) | 2017-04-20 | — | — | US | disclosed |
| US-20170100377-A1 | Solid Oral Pharmaceutical Compositions for Isoxazoline Compounds | INTERVET INC. (US) | 2017-04-13 | — | — | US | disclosed |
| US-20170071914-A1 | Topical Localized Isoxazoline Formulation | INTERVET INC. (US) | 2017-03-16 | — | — | US | disclosed |
| US-20170062744-A1 | CYCLIC AMINE SURFACE MODIFIER AND ORGANIC ELECTRONIC DEVICES COMPRISING SUCH CYCLIC AMINE SURFACE MODIFIER | MERCK PATENT GMBH (DE) | 2017-03-02 | — | — | US | disclosed |
| US-20170062722-A1 | Methoxyaryl Surface Modifier and Organic Electronic Devices comprising such Methoxyaryl Surface Modifier | MERCK PATENT GMBH (DE) | 2017-03-02 | — | — | US | disclosed |